Download Sample
Add to CartUltraviolet (UV) Infection Control Device (ICD) Market
By Type;
Mobile Type and Stationary TypeBy Component Type;
UV Lamps and Quartz SleevesBy Application;
Water, Wastewater & Process Water Treatment, Air Treatment and Surface DisinfectionBy End User;
Hospitals, Medical Device Companies, Clinics & Laboratories, Pharmaceutical Companies, Food Industry and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Ultraviolet (UV) Infection Control Device (ICD) Market Overview
UV Infection Control Device (Icd) Market (USD Million)
UV Infection Control Device (Icd) Market was valued at USD 462.10 million in the year 2024. The size of this market is expected to increase to USD 702.25 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.
Ultraviolet (UV) Infection Control Device (ICD) Market
*Market size in USD million
CAGR 6.2 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.2 % |
| Market Size (2024) | USD 462.10 Million |
| Market Size (2031) | USD 702.25 Million |
| Market Concentration | Medium |
| Report Pages | 392 |
Major Players
- STERIS Corporation
- Advanced Sterilization Products (ASP)
- Xenex Disinfection Services LLC
- Getinge Group
- Lumalier Corporation
- Atlantic Ultraviolet Corporation
- American Ultraviolet
- AquiSense Technologies
- Halma plc (UVEXS)
- Clorox Healthcare
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Ultraviolet (UV) Infection Control Device (ICD) Market
Fragmented - Highly competitive market without dominant players
The Ultraviolet (UV) Infection Control Device (ICD) Market is growing rapidly as healthcare facilities and public institutions adopt advanced disinfection solutions. Using UV-C light, these devices effectively deactivate harmful microorganisms to maintain sterile environments. At present, almost 60% of hospitals integrate UV devices into infection control strategies, underscoring their rising adoption.
Growing Demand for Effective Disinfection
Increasing focus on infection prevention is propelling the use of UV devices. Compared to traditional cleaning methods, UV disinfection provides faster sterilization with proven pathogen elimination. Studies reveal that over 55% of healthcare professionals prefer UV-based solutions in high-risk environments, highlighting their reliability and efficiency in ensuring safety.
Technological Innovations in UV Devices
Advancements in UV technology are enhancing device performance and usability. Innovations such as automated UV robots, portable sterilizers, and room-scale disinfection systems are broadening the scope of UV devices. Approximately 40% of new launches in the infection control segment now feature UV-C integration, demonstrating strong industry commitment to innovation.
Clinical and Economic Benefits
The deployment of UV infection control devices delivers measurable clinical and economic benefits. Evidence shows a 35% decline in healthcare-associated infections and a 25% reduction in treatment expenses. These benefits not only improve patient outcomes but also support greater hospital efficiency by reducing extended stays.
Future Growth Prospects
The outlook for this market is highly favorable, supported by expanding research initiatives and applications beyond healthcare. Nearly 50% of infection prevention programs now employ UV-based devices. With rising awareness, proven effectiveness, and continued technological progress, the ultraviolet infection control device market is positioned for long-term growth.
UV Infection Control Device (Icd) Market Recent Developments
-
May 2022: GlaxoSmithKline made a significant announcement, revealing its intention to invest up to USD 3.3 billion in the acquisition of the privately held biopharmaceutical firm Affinivax. This strategic move aims to strengthen GSK's vaccine pipeline, a crucial focus area as the British pharmaceutical company prepares to separate its consumer unit.
-
March 2022: The University of Maryland School of Medicine (UMSOM) spearheaded a research initiative aimed at evaluating the efficacy of the meningococcal vaccine for infants and young children in Africa. The successful outcome of this study could potentially pave the way for approval by the World Health Organization (WHO) for the vaccine's use in this region.
UV Infection Control Device (Icd) Market Segment Analysis
In this report, the UV infection control device (Icd) market has been segmented by Type, End user, Application and Geography.
UV Infection Control Device (Icd) Market, Segmentation by Type
The segmentation of the UV Infection Control Device (ICD) Market by Type into, Mobile Type ,and Stationary Type.
Mobile Type
Mobile units account for about 60% of the UV Infection Control Device Market, favored for rapid room-to-room deployment and flexible coverage across care settings. Providers emphasize workflow efficiency, device innovation, and integrated technological advancements to maximize cycle effectiveness. Vendor–facility partnerships and procurement strategies are accelerating growth and network-wide expansion with a strong future outlook.
Stationary Type
Stationary systems represent roughly 40%, anchored in high-throughput zones where consistent exposure protocols are essential. Hospitals prioritize automated cycles, interoperability, and safety features that enhance operational efficiency and compliance. Long-term service collaboration, software-driven innovation, and outcome-focused strategies support durable adoption and sustained growth.
UV Infection Control Device (Icd) Market, Segmentation by End User
The segmentation of the UV Infection Control Device (ICD) Market by End-User into, Hospitals, Medical Device Companies, Clinics & Laboratories, Pharmaceutical Companies, and Food Industry & Others
Hospitals
Hospitals account for about 40% of UV ICD adoption, driven by stringent infection prevention goals and high room-turnover needs. Large facilities prioritize device innovation, automated cycle logging, and interoperability with environmental services software. Strong vendor–provider collaboration and documented compliance gains are sustaining multi-site rollouts and steady growth.
Medical Device Companies
Medical device manufacturers represent roughly 18%, using UV systems to support cleanroom bioburden control and pre-pack assembly areas. Inline UV stations and batch chambers improve workflow efficiency while reinforcing GMP-aligned sanitation protocols. Data-rich validation and supplier partnerships are expanding standardized usage across plants.
Clinics & Laboratories
Clinics & Laboratories comprise around 20%, favoring compact UV units for fast turnaround, benchtop decontamination, and specimen-handling zones. Adoption centers on biosafety enhancements, cycle traceability, and staff training to meet accreditation expectations. Portable devices and procurement strategies enable scalable deployments across networks.
Pharmaceutical Companies
Pharmaceutical companies hold approximately 12%, leveraging UV for aseptic support in staging rooms, gowning areas, and material transfer points. Integrated monitoring and documented compliance strengthen audit readiness and reduce manual disinfectant load. Cross-functional collaboration with QA and engineering teams accelerates standardized implementation.
Food Industry & Others
Food Industry & Others contribute close to 10%, applying UV for conveyor, packaging, and cold-room surface hygiene. Programs emphasize HACCP alignment, rapid cycle times, and measurable microbial reduction on contact surfaces. Expanding partnerships and service models support adoption in hospitality, transit, and public facilities.
UV Infection Control Device (Icd) Market, Segmentation by Application
The segmentation of the UV Infection Control Device (ICD) Market by application into, Water, Wastewater & Process Water Treatment, Air Treatment, and Surface Disinfection
Water, Wastewater & Process Water Treatment
The UV Infection Control Device (ICD) Market concentrates about 50% of deployments in combined water, wastewater & process water treatment, where continuous flows and stringent quality thresholds prevail. Utilities and industrial plants are scaling automated monitoring, high-output lamps, and skid integrations to accelerate technological advancements and lifecycle performance. Operator–supplier collaboration around validation and platform standardization is fueling network growth across municipal and industrial networks.
Air Treatment
Air treatment accounts for roughly 30%, propelled by demand in hospitals, transit hubs, and commercial buildings seeking continuous airborne pathogen control. Facilities are adopting in-duct arrays and upper-room fixtures with sensors and analytics; vendor–owner partnerships guide rollout roadmaps and service depth. Strengthening standards and efficacy data are driving innovation and a constructive future outlook for large-scale retrofits.
Surface Disinfection
Surface disinfection represents about 20%, focused on rooms, equipment bays, and high-touch zones where rapid cycles and audit trails are critical. Mobile carts and enclosed chambers with dosimetry and reporting elevate compliance and workflow efficiency while simplifying staff training. Mature service models and cross-site collaboration are supporting targeted expansion across healthcare, pharma, and food environments.
UV Infection Control Device (Icd) Market, Segmentation by Geography
In this report, the UV Infection Control Device (Icd) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
UV Infection Control Device (Icd) Market Share (%), by Geographical Region
North America
This region accounts for about 36% of the UV Infection Control Device (ICD) Market, supported by mature healthcare infrastructure, strict infection prevention standards, and rapid adoption of technological advancements. Hospital networks emphasize data-logged cycles, interoperability, and vendor collaboration to scale deployments. Favorable procurement strategies and service models underpin sustained growth and a strong future outlook.
Europe
Europe holds roughly 27%, driven by guideline-aligned environmental hygiene programs and broad facility retrofits. Health systems prioritize safety, automated reporting, and cross-border partnerships that accelerate device innovation. Centralized tenders and lifecycle-cost strategies support steady expansion across acute and long-term care.
Asia Pacific
Asia Pacific represents approximately 24%, expanding quickly with new hospitals, industrial upgrades, and increasing air and surface disinfection needs. Local–global collaboration is improving access, while smart-building integrations showcase technological advancements at scale. Government-backed modernization and training pipelines are fueling market growth.
Middle East & Africa
This region comprises about 7%, with momentum from center-of-excellence build-outs and accreditation-driven protocols. Public–private partnerships enhance equipment availability, analytics, and staff readiness. Stepwise infrastructure upgrades and standardized workflow efficiency support measured expansion.
Latin America
Latin America contributes close to 6%, led by urban systems upgrading ORs, labs, and HVAC-linked air treatment. Provider–supplier collaboration and value-based procurement strategies improve uptime and compliance. Focused training and device innovation are strengthening reliability and medium-term growth.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global UV Infection Control Device (Icd) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Growing Healthcare Awareness
- Increasing Hospital Acquisitions
- Stringent Regulatory Standards
- Technological Advancements
-
Rising Demand Globally : The rising demand for UV infection control devices globally is fueled by the increasing awareness among healthcare professionals and patients alike regarding the importance of infection prevention. This heightened awareness is driven by the growing number of healthcare-associated infections (HAIs) and the need for effective solutions to combat them. Hospitals and healthcare facilities are actively seeking ways to enhance their infection control protocols, leading to a surge in demand for UV ICDs. Additionally, advancements in technology have made UV devices more efficient and user-friendly, further driving their adoption across various healthcare settings.
Moreover, the COVID-19 pandemic has accelerated the adoption of UV infection control devices, as healthcare facilities prioritize measures to mitigate the spread of the virus. UV technology offers a non-toxic and chemical-free solution for disinfection, making it particularly appealing in healthcare settings where patient safety is paramount. As a result, the demand for UV ICDs is expected to continue growing as healthcare facilities invest in robust infection control strategies to safeguard patients and staff members.
Furthermore, the globalization of healthcare has led to increased awareness and adoption of UV infection control devices in emerging markets. Countries with developing healthcare infrastructure are recognizing the importance of infection prevention and are investing in advanced technologies to improve healthcare outcomes. This presents significant opportunities for market players to expand their presence in these regions and tap into the growing demand for UV ICDs.
Restraints
- High Initial Costs
- Limited Awareness
- Safety Concerns
- Complex Regulatory Landscape
-
Disinfection Misconceptions : One of the significant restraints facing the global UV infection control device market is the presence of misconceptions surrounding disinfection methods. Despite the proven efficacy of UV technology in killing pathogens, there exists a lack of awareness and understanding among healthcare professionals and the general public regarding its capabilities. This misconception often leads to skepticism and reluctance towards adopting UV ICDs, particularly in regions where traditional disinfection methods are more widely accepted.
Additionally, concerns about the safety of UV radiation pose a barrier to widespread adoption. While UV-C radiation is effective in killing pathogens, prolonged exposure can have harmful effects on human health, including skin and eye damage. Consequently, healthcare facilities may hesitate to implement UV ICDs due to safety concerns for patients and staff. Addressing these safety concerns through proper training and education is essential to overcome this restraint and promote the adoption of UV infection control devices.
Furthermore, the complex regulatory landscape surrounding UV technology presents challenges for market players seeking to commercialize their products. Different countries have varying regulations and standards governing the use of UV devices, requiring manufacturers to navigate multiple regulatory frameworks to ensure compliance. This can lead to delays in market entry and increased costs associated with regulatory approvals, hindering the growth of the UV ICD market.
Opportunities
- Emerging Markets Expansion
- Innovations in UV Technology
- Integration with IoT
- Focus on Portable Devices
-
Increasing Research Funding : With increasing research funding dedicated to infection control and prevention, there are ample opportunities for innovation and technological advancements in the global UV infection control device market. Research institutions and healthcare organizations are investing in studies to evaluate the efficacy of UV technology in eliminating a wide range of pathogens, including emerging infectious diseases. These research efforts not only contribute to the scientific understanding of UV disinfection but also drive the development of next-generation UV ICDs with improved performance and capabilities.
Moreover, the integration of UV devices with Internet of Things (IoT) technology presents exciting opportunities for market growth. IoT-enabled UV ICDs can offer real-time monitoring and control capabilities, allowing healthcare facilities to optimize disinfection protocols and ensure compliance with regulatory standards. This connectivity also facilitates data-driven insights into infection control practices, enabling continuous improvement and proactive management of healthcare-associated infections.
Additionally, the focus on portable UV ICDs opens up new avenues for market expansion, particularly in non-traditional healthcare settings such as ambulatory care centers and long-term care facilities. Portable devices offer flexibility and convenience in disinfection, allowing healthcare providers to address infection control needs in various environments. As the demand for mobile healthcare solutions continues to rise, portable UV ICDs are poised to play a crucial role in enhancing infection prevention strategies and improving patient outcomes.
Competitive Landscape Analysis
Key players in Global UV Infection Control Device (Icd) Market include :
- STERIS Corporation
- Advanced Sterilization Products (ASP)
- Xenex Disinfection Services LLC
- Getinge Group
- Lumalier Corporation
- Atlantic Ultraviolet Corporation
- American Ultraviolet
- AquiSense Technologies
- Halma plc (UVEXS)
- Clorox Healthcare
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Component Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Ultraviolet (UV) Infection Control Device (ICD) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing Healthcare Awareness
- Increasing Hospital Acquisitions
- Stringent Regulatory Standards
- Technological Advancements
- Rising Demand Globally
- Restraints
- High Initial Costs
- Limited Awareness
- Safety Concerns
- Complex Regulatory Landscape
- Disinfection Misconceptions
- Opportunities
- Emerging Markets Expansion
- Innovations in UV Technology
- Integration with IoT
- Focus on Portable Devices
- Increasing Research Funding
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Ultraviolet (UV) Infection Control Device (ICD) Market, By Type, 2021 - 2031 (USD Million)
- Mobile Type
- Stationary Type
-
Ultraviolet (UV) Infection Control Device (ICD) Market, By Component Type, 2021 - 2031 (USD Million)
-
UV Lamps
-
Quartz Sleeves
-
- Ultraviolet (UV) Infection Control Device (ICD) Market, By Application, 2021 - 2031 (USD Million)
- Water
- Wastewater & Process Water Treatment
- Air Treatment
- Surface Disinfection
- Ultraviolet (UV) Infection Control Device (ICD) Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Medical Device Companies
- Clinics & Laboratories
- Pharmaceutical Companies
- Food Industry
- Others
- Ultraviolet (UV) Infection Control Device (ICD) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Ultraviolet (UV) Infection Control Device (ICD) Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- STERIS Corporation
- Advanced Sterilization Products (ASP)
- Xenex Disinfection Services LLC
- Getinge Group
- Lumalier Corporation
- Atlantic Ultraviolet Corporation
- American Ultraviolet
- AquiSense Technologies
- Halma plc (UVEXS)
- Clorox Healthcare
- Company Profiles
- Analyst Views
- Future Outlook of the Market